Background illustration for clinical trials search

Paid Clinical Trials Lubbock

Discover 97 paid clinical trials in Lubbock, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Effect of Ultrasound-Guided Dry Needling Targeting Rectus Capitus Posterior Major on Individuals With Headaches

for
Headache Disorders, Primary, Headache, Cervicogenic
Location: Lubbock TX
Sponsor: Texas Tech University Health Sciences Center

Sex: All

Age: 18 - 65

Code: NCT07309874

Recruiting

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

for
Renal Cell Carcinoma
Location: Lubbock TX, Dallas TX, Lone Tree CO, Aurora CO,
Sponsor: HiberCell, Inc.

Sex: All

Age: 18+

Code: NCT06234605

Phase1, Recruiting

Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge

for
Penicillin Allergy
Location: Lubbock TX
Sponsor: James Tarbox, MD

Sex: All

Age: 18 - 70+

Code: NCT06303128

Phase3, Recruiting

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

for
Anthracycline Related Cardiotoxicity in Breast Cancer
Location: Lubbock TX
Sponsor: Texas Tech University Health Sciences Center

Sex: All

Age: 18 - 70+

Code: NCT03934905

Phase1, Phase2, Recruiting

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

for
Amblyopia
Location: Lubbock TX, Fort Worth TX, Oklahoma City OK,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 3 - 13

Code: NCT04378790

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease

for
Proteinuric Kidney Disease
Location: Lubbock TX, Fort Worth TX, Lewisville TX, Mansfield TX,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 10 - 65

Code: NCT05312879

Phase2, Phase3, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Lubbock TX, Fort Worth TX, Oklahoma City OK,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase3, Recruiting

Clinical Pre-screening Protocol for Ovarian Cancer

for
Ovarian Cancer
Location: Lubbock TX, Oklahoma City OK, Albuquerque NM,
Sponsor: Allarity Therapeutics

Sex: Female

Age: 18+

Code: NCT03877796

Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Lubbock TX, Fort Worth TX, Oklahoma City OK,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Lubbock TX, Fort Worth TX, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Lubbock TX, Fort Worth TX, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase2, Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Lubbock TX, Denton TX, Bedford TX, Grapevine TX,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Lubbock TX, Fort Worth TX, Oklahoma City OK, El Paso TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase3, Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Lubbock TX, Fort Worth TX, Oklahoma City OK,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase3, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Lubbock TX, Fort Worth TX, Oklahoma City OK,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase3, Recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

for
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor,
Location: Lubbock TX, Fort Worth TX, Oklahoma City OK,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT04322318

Phase2, Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Lubbock TX, Fort Worth TX, Oklahoma City OK,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 22

Code: NCT04726241

Phase1, Phase2, Recruiting

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

for
Childhood Extracranial Germ Cell Tumor,
Location: Lubbock TX, Lawton OK, Fort Worth TX, Oklahoma City OK,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT03067181

Phase3, Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Location: Lubbock TX, Fort Worth TX, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase3, Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Lubbock TX, Fort Worth TX, Oklahoma City OK, El Paso TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 30

Code: NCT06172296

Phase3, Recruiting